Navigation Links
Cardio3 BioSciences Raises EUR13.7 Million in Series B Fundraising and Grant Funding
Date:1/19/2009

MONT-SAINT-GUIBERT, Belgium, January 19 /PRNewswire/ --

- New Funds to Drive Clinical Development of C-Cure(R), a Second-Generation Cell-Based Therapy for Heart Failure

Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, has raised EUR7.2 million in a successful Series B fund raising round. The new funds, which have come from a range of new and existing investors, will be used to finance the clinical development of the Company's lead product. C-Cure is a unique therapy that allows the differentiation of a patient's own cells into 'cardiopoietic' cells which grow into new heart cells and repair heart muscle. C-Cure holds the promise for a treatment that could fundamentally change the future of heart failure patients, one of the world's largest medical needs. The Company plans to enrol shortly approximately 240 patients in a clinical trial with C-Cure to evaluate its potential in the treatment of heart failure.

Cardio3 BioSciences was founded in 2007 by clinicians from the Cardiovascular Center in Aalst, Belgium with a vision of using a cell-based approach for the treatment of heart disease. The Company is led by a senior management team with extensive experience in developing and commercialising pharmaceutical and medical technologies and leverages proprietary technology developed by researchers from Mayo Clinic, a shareholder in the company. Following the successful B series fund raising, Cardio3 BioSciences has added new investors including the Belgium-based investment group Life Science Research Partners, a Luxemburg-based venture capital firm, Hunza Ventures II that focuses on life sciences, IT and cleantech industries, and Grifols, a Spanish holding company specialising in the pharmaceutical hospital industry. Other new investors were not disclosed.

In parallel with this equity fund
'/>"/>

SOURCE Cardio3 BioSciences
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
2. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
3. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
4. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
5. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
6. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
7. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
8. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
9. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... 2015 Pharma Major Lupin ... participación en ZAO "Biocom" en Rusia bajo ciertas ... de Lupin en el mercado farmacéutico de Rusia ... colocándolo como uno de los 10 principales mercados ... más de una década, el mercado farmacéutico ruso ...
(Date:7/2/2015)... 2015 Leading organizations have increasingly started ... and market insights in internal market research studies. ... it is essential for executives to fully understand ... capture critical business-related insights. According to ... LLC, most benchmarked companies find it impossible to ...
(Date:7/2/2015)... SAN DIEGO , July 2, 2015 ResMed ... report its fourth quarter and fiscal year ended June 30, ... York Stock Exchange market close. A press release with ResMed,s ... and the company will host a webcast to discuss operating ... scheduled to begin at 1:30 p.m. US Pacific Time and ...
Breaking Medicine Technology:Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Leveraging Employee Insights to Produce Cutting-Edge Market Research 2ResMed to Announce Fourth Quarter and Fiscal Year-End 2015 Results 2
... ... Jolla-, ... /PRNewswire-,FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a,biopharmaceutical company ... organization, today announced,that an agreement has been executed licensing classes of ...
... The Quigley,Corporation (Nasdaq: QGLY ) announced positive ... subsidiary, Quigley Pharma Inc., which was,conducted in chickens ... The compound was administered to chicks that had ... from the study indicated,that QR448(a) is efficacious against ...
Cached Medicine Technology:Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 2Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 3Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 2Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 3Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 4Quigley Announces Successful Poultry Study of Chickens With Infectious Bronchitis; Plans to Approach the Poultry Industry for Potential Commercialization 5
(Date:7/4/2015)... ... July 04, 2015 , ... Tyler Boden, Project ... technical sales expertise from the North American Board of Certified Energy Practitioners (NABCEP®), ... most highly respected and well established national certification organization for renewable energy professionals. ...
(Date:7/3/2015)... Angeles, CA (PRWEB) , ... July 03, 2015 ... ... was opened for enrollment on July 2nd creating a buzz of media attention. ... has been published online by HonestyFirstReviews.com's Tiffany Hendricks. , "These days many people ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... lineup for its 2015 Annual Conference , the premiere continuing education ... the Renaissance Orlando at SeaWorld in Orlando, Florida. Speakers include the leading ...
(Date:7/3/2015)... ... July 03, 2015 , ... Renowned rhinoplasty surgeon ... the 2016 Dallas Rhinoplasty Symposium . To be held from March 4th - ... be held at the Westin Galleria Dallas. , Designed to take participants from the ...
(Date:7/3/2015)... KS (PRWEB) , ... July 03, 2015 , ... ... dedicated exclusively to healthcare providers, has been retained to lead a national ... One of the top-ranked executive search firms in the healthcare industry, B. E. ...
Breaking Medicine News(10 mins):Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 2Health News:Local Solar Professional Earns Industry's Most Prestigious Certification 3Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 2Health News:High Performance Academy - Review Of Brendon Burchard's New High Performance Training Program Released 3Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 2Health News:RNS Announces Sessions and Speaker Lineup for the 2015 Annual Conference of the Rheumatology Nurses Society 3Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 2Health News:Dr. Rod J. Rohrich Announces the Dates for 2016 Dallas Rhinoplasty Symposium 3Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 2Health News:Jane Phillips Medical Center Retains B. E. Smith to Recruit New Chief Nursing Officer 3
... Development and Research Institutes, Inc (NDRI) in New ... Illinois explored the role// of social supports, spirituality, ... process of recovery from addiction. The study reveals ... well as a decrease in stress when people ...
... death after being whisked away from her husband .Jim Albo, one ... about some good to the quality of care to the senior ... husband who was also being treated at the same hospital, Kootenay ... together for seven decades. Two days after she was moved to ...
... study appearing in the current issue of the American ... help reduce risk of dementia,.// ,The amount of ... of having cognitive impairment in the aging process was ... Kuriyama of Tohoku University Graduate School of Medicine and ...
... regular peelings and scrubbing with a brush can help to ... during pregnancy. // ,Peelings and washings increase circulation and ... is true of massages. ,When stretch marks are ... can help. ...
... kept alive with a Berlin heart until a real one was ... received a new donated heart and is now back home in ... ,Claudia was only the second small child to be ... which first carried out the operation in November 2004. ...
... the opinion that the Police have become the frontline of ... and support mechanisms amongst the community. ,This public ... police shot dead a mentally ill person in West of ... system means that the police become the frontline of mental ...
Cached Medicine News:Health News:Drug Addiction Recovery Buffered by Spirituality 2
... CT MIYABI system is a ... CT scanner on rails (Sliding ... angiography unit. Both systems use ... which can be switched between ...
Spring Type with lock. Titanium....
... ease of the World's First Hand-Held Autorefractor/Keratometer. ... accuracy, reliability and performance Share the Retinomax ... no wires to limit, you can use ... range and advanced measurement modes. Readings ...
Introducing the Guidant HEARTSTRING Proximal Seal System. A surgically intuitive system that meets the challenge of clampless hemostasis with a design that is elegant in its simplicity and profound i...
Medicine Products: